![]() |
|
|
Vol. 60, Issue 6, 1356-1364, December 2001
Department of Pharmacology and Toxicology, Indiana University
School of Medicine, Indianapolis, Indiana (K.R.B., H.R.B.); and
Department of Pharmacology, Faculty of Pharmacy, University of Ankara,
Tandogan, Ankara, Turkey (Ü.D.D.)
Studies have shown that evoked calcium release from sarcoplasmic
reticulum is compromised in diabetic rat hearts. The present study was
undertaken to determine whether this decrease might be ascribed to a
reduction in expression and/or alteration in function of ryanodine
receptor (RyR2) and whether changes could be minimized with insulin
treatment. Hearts were isolated from 4- and 6-week streptozotocin
(STZ)-induced diabetic, 4-week diabetic/2-week insulin-treated, and
age-matched control rats. RyR2 mRNA and protein levels were determined
using reverse transcription-polymerase chain reactions and
polyacrylamide gel electrophoresis, respectively, whereas the
functional integrity of RyR2 was assessed from their ability to bind
[3H]ryanodine. RyR2 protein was unchanged with up to 6 weeks of untreated STZ-induced diabetes. Two weeks of insulin treatment initiated after 4 weeks of diabetes increased RyR2 mRNA levels by 42%
and RyR2 protein levels by 45 to 61%. At equivalent amounts, RyR2
protein from 4-week STZ-induced diabetic rat hearts bound 9% less
[3H]ryanodine than age-matched control rats (74.1 ± 3.9 versus 67.4 ± 3.4 fmol/µg RyR2), whereas that from 6-week
STZ-diabetic rats bound 36% less than control rats (47.9 ± 4.8 versus 74.2 ± 4.5 fmol/µg RyR2, p < 0.05).
RyR2 from insulin-treated animals bound significantly less
[3H]ryanodine than control rats (65.2 ± 4.9 fmol/µg RyR2, p < 0.05). Apparent affinity of
ryanodine for RyR2 was similar among all groups
(Kd
1.04 ± 0.08 nM). Because
expression did not change significantly but ryanodine binding
decreased, these data suggest that the functional integrity of RyR2 is
compromised in diabetic rat hearts, and these changes can be attenuated
with 2 weeks of insulin treatment.
This article has been cited by other articles:
![]() |
B. M. R. Carvalho, R. A. Bassani, K. G. Franchini, and J. W. M. Bassani Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1803 - H1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yaras, M. Ugur, S. Ozdemir, H. Gurdal, N. Purali, A. Lacampagne, G. Vassort, and B. Turan Effects of Diabetes on Ryanodine Receptor Ca Release Channel (RyR2) and Ca2+ Homeostasis in Rat Heart Diabetes, November 1, 2005; 54(11): 3082 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bidasee, Y. Zhang, C. H. Shao, M. Wang, K. P. Patel, U. D. Dincer, and H. R. Besch Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase Diabetes, February 1, 2004; 53(2): 463 - 473. [Abstract] [Full Text] |
||||
![]() |
K. R. Bidasee, K. Nallani, Y. Yu, R. R. Cocklin, Y. Zhang, M. Wang, U. D. Dincer, and H. R. Besch Jr. Chronic Diabetes Increases Advanced Glycation End Products on Cardiac Ryanodine Receptors/Calcium-Release Channels Diabetes, July 1, 2003; 52(7): 1825 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bidasee, K. Nallani, H. R. Besch Jr., and U. D. Dincer Streptozotocin-Induced Diabetes Increases Disulfide Bond Formation on Cardiac Ryanodine Receptor (RyR2) J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 989 - 998. [Abstract] [Full Text] [PDF] |
||||